AcelRx Pharma Says, On Nov 29, Co Got Notice From Patheon Pharma That It Intends To Terminate Manufacturing Services Agreement Between Parties - Filing

Published on December 05, 2022 03:09 PM PST

AcelRx Pharma Says, On Nov 29, Co Got Notice From Patheon Pharma That It Intends To Terminate Manufacturing Services Agreement Between Parties - Filing — Image source: ©2022 Kalkine Media®

Dec 5 (Reuters) - AcelRx Pharmaceuticals Inc:

* ACELRX PHARMA- ON NOV 29, CO GOT NOTICE FROM PATHEON PHARMA THAT IT INTENDS TO TERMINATE MANUFACTURING SERVICES AGREEMENT BETWEEN PARTIES

* ACELRX PHARMACEUTICALS INC - BASED ON PATHEON’S DATE OF NOTICE, MSA WILL TERMINATE ON MAY 31, 2024

* ACELRX PHARMACEUTICALS INC - PATHEON WILL CONTINUE TO SUPPLY PRODUCT UNDER MSA UNTIL TERMINATION DATE

* ACELRX PHARMA- THE COMPANY EXPECTS TO DISCUSS A TRANSITION PLAN WITH PATHEON IN THE NEAR FUTURE Further company coverage:

Reuters

Reuters -
96361 Posts
...

Disclaimer

The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.